We are live on ! Find out more
XXV

IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN
XXV

Delisted

XXV was delisted on the 12th of April, 2018.

Back to rankings

4 hedge funds and large institutions have $2.46M invested in IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

58% more capital invested

Capital invested by funds: $1.56M → $2.46M (+$907K)

0% more funds holding

Funds holding: 4 → 4 (0)

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
–
Calls
$4.88M
Puts
–
Net Calls
+$4.88M
Net Calls Change
+$4.88M

Top Buyers

Rank Fund Capital Flow
1
Barclays
Barclays
United Kingdom
+$891K
2
VF
Virtu Financial
New York
+$84.5K

Top Sellers

Rank Fund Capital Flow
1
U
UBS
Switzerland
-$63.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
1
Barclays
United Kingdom
$1.22M +$891K +23,214 +262%
VF
2
Virtu Financial
New York
$964K +$84.5K +2,200 +10%
U
3
UBS
Switzerland
$232K -$63.4K -1,650 -21%
FTUS
4
Flow Traders U.S.
New York
$48K – – –

XXV Hedge Fund Activity: Q3 2013 in Review

4 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN (XXV) for Q3 2013, worth a combined $2.46M — up 58% from $1.56M a quarter earlier.

Fund positioning in XXV was balanced in Q3 2013: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 1 trimmed.

The largest buyer was Barclays, adding an estimated $891K. The largest seller was UBS, cutting an estimated $63.4K.

  • 4 institutional investors held IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN (XXV) as of Q3 2013, unchanged from Q2 2013.
  • Funds reported $2.46M of IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN stock for Q3 2013, up 58% quarter-over-quarter.
  • 0 funds opened new IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN positions in Q3 2013 and 0 closed out.
  • The largest IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN buyer in Q3 2013 was Barclays, an estimated $891K added.
  • The largest IPATH INVERSE S&P 500 VIX SHORT-TERM FUTURES ETN seller in Q3 2013 was UBS, an estimated $63.4K sold.

Based on aggregated 13F filings for Q3 2013.